Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jan 24.
Published in final edited form as: Biochemistry. 2007 Sep 29;46(42):11969–11978. doi: 10.1021/bi700925n

Characterization of Alkyl-Nickel Adducts Generated by Reaction of Methyl-Coenzyme M Reductase with Brominated Acids

Mishtu Dey , Ryan C Kunz , Derek M Lyons §, Stephen W Ragsdale ‡,*
PMCID: PMC3553217  NIHMSID: NIHMS62749  PMID: 17902704

Abstract

Methyl-coenzyme M reductase (MCR) from methanogenic archaea catalyzes the final step in the biological synthesis of methane. Using coenzyme B (CoBSH) as the two-electron donor, MCR reduces methyl-coenzyme M (methyl-SCoM) to methane and the mixed disulfide, CoB-S-S-CoM. MCR contains Coenzyme F430, an essential redox-active nickel tetrahydrocorphin at its active site. The active form of MCR (MCRred1) contains Ni(I)-F430. When 3-bromopropane sulfonate (BPS) is incubated with MCRred1, an alkyl-Ni(III) species is formed that elicits the MCRPS EPR signal. Here we used EPR and UV-visible spectroscopy and transient kinetics to study the reaction between MCR from Methanothermobacter marburgensis and a series of brominated carboxylic acids, with chain lengths from 4 to 16 carbons long. All of these compounds give rise to an alkyl-Ni intermediate with an EPR signal similar to that of the MCRPS species. Reaction of the alkyl-Ni(III) adduct, formed from brominated acids with 8 or less total carbons, with HSCoM as nucleophile at pH 10.0 results in the formation of a thioether coupled to regeneration of the active MCRred1 state. When reacted with 4-bromobutyrate, MCRred1 forms the alkyl-Ni(III) MCRXA state and then, surprisingly, undergoes “self-reactivation” to regenerate the Ni(I) MCRred1 state and a bromocarboxy ester. The results demonstrate an unexpected reactivity and flexibility of the MCR active site to accommodate a broad range of substrates, which act as molecular rulers for the substrate channel in MCR.


Methanogenic archaea are anaerobic microbes that form methane as an end product of their metabolism. Methanogens produce approximately 1 billion tons of methane every year, providing a valuable source of renewal energy. On the other hand, methane is a greenhouse gas that is 20 times more potent than CO2 and therefore poses potential environmental problems (1). Methyl coenzyme M reductase (MCR), found in all methanogens, is a nickel containing enzyme that catalyzes the terminal step in biological methane formation, which is the reduction of methyl-coenzyme M (2-(methylthiol)ethane sulfonate, methyl-SCoM) with the two-electron donor coenzyme B, (N-7-mercaptoheptanolyl-threonine phosphate, CoBSH), to form methane and the heterodisulfide CoBS-SCoM (1-3). There is strong evidence that MCR or a MCR-like enzyme also catalyzes the first step in the anaerobic oxidation of methane (4). The active site of MCR contains a redox-active Ni-tetrapyrrolic cofactor called coenzyme F430 (or simply F430) that is thought to play an essential role in catalysis (5-7). The crystal structure(s) of MCR reveals that F430 is non-covalently bound to MCR and sits at the bottom of a 30 Å hydrophobic channel (8) that is sufficiently deep to accommodate both substrates.

The Ni atom of F430 in MCR can exist in 3 different oxidation states, each exhibiting several coordination states. Active MCRred1 contains Ni(I), which is the form that can react with methyl-SCoM to catalyze methane formation (9, 10). In addition to MCRred1, two other states of MCR that could be relevant for the catalytic mechanism are MCRox1 and MCRPS.

Based on spectroscopic and computational studies, MCRox1 is best described as a high spin Ni(II)/thiyl-radical that is in resonance with a Ni(III)/thiolate species (11, 12). MCRox1 resembles a proposed catalytic intermediate and is called the “ready state” (9) because it can be converted to MCRred1 in vitro by incubation with the low potential reductant, titanium(III) citrate (Ti(III) citrate) (10). MCRox1 is generated in vivo by treating the actively growing cells with sodium sulfide (13) or alternatively, by switching the gas from 80%H2/20%CO2 to 80%N2/20%CO2 (14). MCRox1 can be generated in vitro by treating MCRred2 (MCRred1 in the presence of HSCoM and CoBSH) with polysulfide (15).

The second state of MCR that may be relevant for catalysis is MCRPS (formerly MCRBPS) (16). MCRPS has been described as a high-spin Ni(II)/alkylsulfonate radical species resonating with a Ni(III)/alkyl species (17, 18), and, thus, resembles the proposed methyl-Ni catalytic intermediate. MCRPS is generated in vitro by incubating MCRred1 with 3-bromopropane sulfonate (BPS) (16), which is a potent inhibitor (apparent Ki = 50 nM) (19, 20) of MCR that also has been classed as an irreversible inhibitor (21). However, when it was recognized that the MCRPS state can be converted back to the active MCRred1 state by reacting with thiolates, reversing inhibition, BPS was classified as a reversible redox inactivator (22). Thus, both MCRPS and MCRox1 are “ready” states that can generate MCRred1 in vitro; furthermore, they exhibit similar UV-visible and EPR spectra.

The two mechanisms for methane formation can be distinguished by the first step of catalysis (Figure 1). In Mechanism I, which is based on the crystal structure and mechanistic work with F430 model complexes (23-25), nucleophilic attack of Ni(I)-MCRred1 on the methyl group of methyl-SCoM generates a methyl-Ni intermediate (26). Although a true methyl-Ni intermediate has not been described upon reaction of MCRred1 with the native substrate methyl-SCoM, the reaction of BPS and other alkyl halides with MCRred1 generates an alkyl-Ni(III) species that is subsequently attacked by free organic thiolates to generate the thioether product and MCRred1 (22). This reaction is analogous to that of the reaction catalyzed by methionine synthase, where homocysteine acts as a nucleophile to reduce methyl-Co(III) to form Co(I) and methionine (27).

Figure 1.

Figure 1

Relationship between MCRox1, MCRPS and the two proposed mechanisms for MCR.

Mechanism II, which is based on density function theory computations (28, 29), avoids the methyl-Ni(III) species because cleavage of the strong methyl-S bond of methyl-SCoM to form a relatively weak methyl-Ni(III) species was calculated to be extremely endothermic (45 kcal/mol). Therefore, Mechanism II proposes attack of Ni(I) on the sulfur atom adjacent to the methyl group of methyl-SCoM resulting in homolytic cleavage of the methyl-sulfur bond to generate a methyl radical and a Ni(III)-thiolate/Ni(II)-thiol-radical complex (MCRox1-like species) (Figure 1).

It was recently shown (22) that the alkyl-Ni(III) species (MCRPS) can be converted to the active MCRred1 state when it is reacted with various thiols at pH 10.0. The MCRPS intermediate is chemically similar to the proposed alkyl-Ni intermediate in the first step of Mechanism I; however, the position of attack on BPS is stereochemically comparable to the first step in Mechanism II. The position of attack by Ni(I) is probably influenced by the placement of BPS (or other analogs) in the active site. Based on the MCRox1-silent crystal structure, the sulfonate group of HSCoM is firmly anchored by three contacts at the “back” of the active site and the thiolate is ligated to Ni. Similarly, the reactivity of CoBSH would be influenced by its location in the substrate channel relative to the position of the Ni-bound ligand. CoBSH has phosphate and carboxylate groups that anchor it to the upper lip of the channel and an alkyl chain that leads into the active site and terminates in a thiol group 8.7 Å from the nickel atom of F430 (8).

In order to better understand the selectivity of the MCR reaction toward nucleophilic attack by Ni(I), one could compare the reactivity of a series of brominated sulfonates of varying chain length. However, such a series of compounds is not commercially available. On the other hand, substitution of the sulfonate of BPS with a carboxylate still allows formation of a MCRPS-like signal (22), which we call MCRXA. Furthermore, methylmercaptopropionate is a substrate for MCR (kcat/KM = 26 M-1 s-1), albeit ~ 110-fold less reactive than the natural substrate, methyl-SCoM (kcat/KM = 2.8 × 103 M-1s-1) (30), and bromopropionate (like BPS) is an inhibitor (18), indicating that brominated carboxylic acids mimic the interactions of BPS and methyl-SCoM at the MCR active site. Therefore, in order to better understand the selectivity of the MCR reaction, we have in this paper compared the reactivity of a series of brominated compounds of varying chain lengths in formation of the alkyl-Ni(III) complexes and in the subsequent reaction with organic thiol to regenerate the active enzyme.

Here we show that various brominated acids ranging from the relatively small bromobutyric acid (Br4A) to the relatively large bromohexadecanoic acid (Br16A) can all react with MCRred1 to form an EPR-active species, MCRXA, that is nearly identical to MCRPS. Based on the present studies a model has been proposed for the mode of binding of various brominated acids of different chain lengths that can be classified as: (a) methyl-SCoM-like and (b) CoBSH-like. The results provide information on the selectivity of MCR for its substrates (methyl-SCoM, CoBSH and BPS) and may aid in the development of other substrate analogs or inhibitors of MCR.

Materials and Methods

Materials and Organism

Methanothermobacter marburgensis (f. Methanobacterium thermoauotrophicum strain Marburg) was obtained from the Oregon Collection of Methanogens (Portland, OR) catalogue as OCM82. All buffers, media ingredients, and other reagents were acquired from Sigma-Aldrich (St. Louis, MO) unless otherwise stated and were of the highest purity available. Solutions were prepared using Nanopure deionized water. N2 (99.98%), H2S (99.0 %), H2/CO2 (80%/20%), and Ultra High Purity (UHP) H2 (99.999%) were obtained from Linweld (Lincoln, NE). Ti(III) citrate solutions were prepared from a stock solution of 200 mM Ti(III) citrate, which was synthesized by adding an aqueous solution of sodium citrate (5.8 g sodium citrate added to 20 ml H2O) to Ti(III) trichloride (30 weight % solution in 2 M hydrochloric acid) (Acros Organics, Morris Plains, NJ) under anaerobic conditions and adjusting the pH to 7.0 with a saturated solution of sodium bicarbonate (31). The concentration of Ti(III) citrate was determined routinely by titrating a methyl viologen solution.

M. marburgensis growth, harvest and MCRred1 purification conditions

MCRred1 was isolated from M. marburgensis cultured on H2/CO2/H2S (80%/20%/0.1%) at 65 °C in a 14-L fermentor (New Brunswick Scientific Co., Inc. New Brunswick, NJ) (9). Culture media were prepared as previously described (32). MCRred1 was generated in vivo and purified as described earlier (22). The purification procedure routinely generates 60-70 % MCRred1 as determined by UV-visible and EPR spectroscopy described earlier (22)

Spectroscopy of MCR

UV-visible spectra of MCR were recorded in the anaerobic chamber using a diode array spectrophotometer (Model DT 1000A, Analytical Instrument Systems, Inc., Flemingron, NJ). EPR spectra were recorded on a Bruker EMX spectrometer (Bruker Biospin Corp., Billerica, MA), equipped with an Oxford ITC4 temperature controller, a Hewlett-Packard Model 5340 automatic frequency counter and Bruker gaussmeter. Unless otherwise noted, the EPR spectral parameters included: temperature, 70 K; microwave power, 10 mW; microwave frequency, 9.43 GHz; receiver gain, 2 × 104; modulation amplitude, 10.0 G; modulation frequency, 100 kHz. Double integrations of the EPR spectra were performed and referenced to a 1 mM copper perchlorate standard.

Stopped-Flow Studies

Stopped-flow experiments were carried on an Applied Photophysics spectrophotometer (SX.MV18, Leatherhead, UK) equipped with a photodiode array detector. Rigorous measures were taken to remove oxygen from the stopped-flow instrument. Buffered solutions of enzymes and inhibitors were made in the anaerobic chamber in 0.5 M Tris-HCl, pH 7.6 containing 0.2 mM Ti(III) citrate at 25 °C. All buffered solutions contained 0.2 mM Ti(III) citrate as an oxygen scavenger, since exclusion of Ti(III) citrate resulted in oxidation of MCRred1. The solutions were then loaded into tonometers, which had been incubated in the anaerobic chamber for at least 4 days and served as reservoirs for the drive syringes of the stopped-flow instrument. The drive syringes and mixing chamber were made anaerobic by flushing the syringe chamber with a dithionite:resazurin (1 mM: 0.02 mM) solution in 0.1M NaOH. MCRred1 and varied concentrations of brominated acids were rapidly mixed at 25 °C in a 1:1 ratio. The reaction was monitored in the single wavelength mode by following the decrease of MCRred1 at 385 nm and MCRXA formation was followed at 420 nm, with a 1 cm pathlength. Data were fit to a single exponential decay and exponential rise to maximum functions, respectively, using software provided by Applied Photophysics (version SX MV.18) or using Sigma Plot 2001 (Point Richmond, CA). Reported rate constants are the average of at least three different rapid-mixing experiments.

Mass spectromety

All mass spectra (LCMS) were collected in negative ion modes by direct infusion to a [4000 Qtrap (ABS)] mass spectrometer using a kD Scientific micro flow syringe pump. The data was acquired and processed using Analyst 1.4.1 software. Data was acquired in Q1 (quadrupole one) and Product ion scan in negative ion mode. The mass range of 50-300 amu (atomic mass units) was scanned in 1s. The ionspray voltage was set to -4500 V, the temperature was set to 22 °C and a declustering potential (DP) value was -50 V. MCRred1 (10 μM) was incubated for 10 min with 2.0 mM 4-bromobutyric acid (Br4A was prepared as a stock solution in 0.1 M formic acid; thus, the final concentration of formic acid in the reaction mixture is 0.4 mM) in 20 mM ammonium carbonate, pH 10.0, and the reaction was followed by UV-visible spectroscopy. For, the regeneration of MCRred1 from MCRXA with HSCoM, typically 20 μM MCRred1 was reacted with 1 mM brominated acid in 50 mM ammonium carbonate, pH 10 to form MCRXA, which was then reacted with 20 mM HSCoM. This reaction was monitored by UV-visible spectroscopy. After MCRred1 was fully reactivated, assessed by reaching a stable maximum absorbance of the 385 nm band, the reaction was stopped by freezing in liquid nitrogen. For analysis, the frozen liquid was thawed and, subsequently, enzyme and ligands were separated using a 0.5 mL Microcon centrifugal filter device with a 30 KDa cut-off filter (Millipore, Billerica, MA). The filtrate containing the product was collected and stored at 4 °C until it was assayed by mass spectrometry. All MS samples were prepared by mixing the ligand solution with an equal volume of acetonitrile.

Reactions between MCRred1 and brominated acids

MCRred1 (typically 0.01-0.02 mM) was incubated in 50 mM Tris-HCl (pH 7.6) at 25 °C for 0.5-2 min, with various brominated acids at concentrations between 0.1 mM and 2 mM: 0.2 mM 4-bromobutyric acid (Br4A) in 0.1 mM final formic acid concentration, 0.2 mM 5-bromovaleric acid (Br5A), 0.2 mM 6-bromohexanoic acid (Br6A), 1.0 mM 7-bromoheptanoic acid (Br7A) (Karl Industries Inc., Aurora, OH and Matrix Scientific, Columbia, SC), 0.1 mM 8-bromooctanoic acid (Br8A), 0.2 mM 9-bromononanoic acid (Br9A) (Matrix Scientific), 0.2 mM 10-bromodecanoic acid (Br10A) (Matrix Scientific), 1.0 mM 11-bromoundecanoic acid (Br11A) (Fluka, St.Louis, MO), 1.0 mM 12-bromododecanoic acid (Br12A) (Fluka), 1.0 mM 15-bromopentadecanoic acid (Br15A) (Fluka), and 0.5 mM 16-bromohexadecanoic acid (Br16A). All brominated acid solutions, with the exception of Br4A, were made in 100 % ethanol. The rate and extent of formation of new MCRXA complexes was measured by EPR spectroscopy (Table 1).

Table 1.

Kinetic parameters for the conversion of MCRred1 to MCRXA.

Chemical Name Chemical Structure MCRred1 → MCRXA (% Conversion)c kmax (s-1) KM (mM) kmax/KM (M-1 s-1)a

Br4A graphic file with name nihms-62749-t0001.jpg 85 ± 15 15 ± 0.6 88 ± 5 170 ± 12
Br5A n = 2 56 ± 10 2.0 ± 0.5 65 ± 27 31 ± 15
Br6A n = 3 53 ± 10 0.27 ± 0.05 5.2 ± 3.6 53 ± 38
Br7A n = 4 93 ± 7 2.2 ± 0.3 21 ± 7 140 ± 57
Br8A n = 5 93 ± 1 2.1 ± 0.5 92 ± 34 23 ± 10
Br9A n = 6 60 ± 2 0.074 ± 0.003 1.3 ± 0.2 56 ± 7
Br10A n = 7 12 ± 8 0.050 ± 0.002 2.2 ± 0.5 22 ± 2
Br11A n = 8 <5 (13 ± 5) 380 ± 170 200 ± 110 1900 ± 1300
1500 ± 80b
Br12A n = 9 <5 (10 ± 5) 0.28 ± 0.02 0.93 ± 0.26 500 ± 92
Br15A n = 12 6 (20 ± 5) 0.26 ± 0.04 0.16 ± 0.11 1600 ± 1000
470 ± 64b
Br16A n = 13 8 (41 ± 2) ND ND 57 ± 18b
a

Second-order rate constants were determined by a hyperbolic fit.

b

Second-order rate constants determined by fitting data to a linear equation.

c

The % conversion was determined by EPR. The number in the parenthesis was obtained when the reaction was performed on ice. For details, refer to experimental section

Special precautions were required for working with 4-bromobutyric acid (Br4A). This compound is unstable in neutral and alkaline solutions; therefore, all experiments were performed by dissolving it in 0.1M formic acid. Attempts to make a solution of Br4A in neutral or high pH solutions or in ethanol resulted in degradation of the acid as we inferred by a decrease in reactivity of Br4A with MCRred1 as a function of time.

Results

MCRXA formation with brominated acids, studied by EPR and UV-visible spectroscopy

Kinetic and spectroscopic studies indicate that, when MCRred1 reacts with BPS, bromide is eliminated to generate a six-coordinate Ni(III)-complex with propylsulfonate as the upper axial ligand, which undergoes protonation to form propanesulfonate (17, 18, 22). This reaction is analogous to the reaction of MCRred1 to generate a methyl-Ni(III) intermediate in methane formation with the natural substrate, methyl-SCoM. Here we expand on a previous study to determine the range of BPS analogs that are accommodated by MCR (22). Instead of sulfonates, we used a series of commercially available brominated carboxylic acids. As described in the Introduction, we hypothesized that the reaction between MCRred1 and brominated acids is similar to that with BPS. To test this hypothesis, EPR and UV-visible spectroscopies were used to observe the formation of the Ni(III)-alkanoic acid complex(s), and stopped-flow experiments were conducted to characterize the kinetic parameters for the reactions. Since MCRXA (alkyl-Ni(III)) and MCRsilent (Ni(II)) exhibit similar UV-visible spectra, unambiguous quantification of the amount of MCRred1 and of MCRXA was performed by EPR spectroscopy by comparing the doubly integrated signal intensity with that of a Cu standard. The concentration of MCRsilent is then equal to the difference between the initial concentration of MCRred1 and the amount of MCRXA. Brominated acids used in this study are abbreviated as BrXA, where X refers to total length of the chain (between 4 and 16 carbons long) including the terminal carboxyl group (A).

MCRred1 reacts with brominated acids that are 4 to 16 carbons in length according to Equation 1 to form MCRXA (X = 4-16), which elicits an EPR signal nearly identical to that of MCRPS (Table 1). A representative EPR spectrum of MCRred1 and MCR7A, the product of the reaction between MCRred1 and Br7A, is shown in Figure 2.

MCRred1+BrXAMCRXA+Br- Equation (1)

Figure 2.

Figure 2

EPR spectra of MCR7A formed from the reaction of MCRred1 with Br7A. MCRred1 (20.6 μM (solid line)) was incubated with 1 mM Br7A (dashed line) or 548 μM BPS (dotted line) in 50 mM Tris-HCl (pH 7.6) with 0.1 mM Ti(III) citrate at 20 °C. *Contamination from MCRox1.

The near identity of the EPR spectrum of the alkyl-Ni(III) MCRPS state with that of MCRXA strongly indicates that the reaction of MCRred1 with the bromoacids also generates an alkyl-Ni(III) species. The different MCRXA complexes accumulate to varying amounts, as reported in Table 1. Those generated from the shorter brominated acids, Br10A and below, form quickly and accumulate to fairly high amounts during a 2-min reaction at room temperature. The shortest acid tested is Br4A, which had earlier been reported to form a MCRPS-like species (17, 18, 22). When reacted with MCRred1, Br4A completely converts to the MCR4A species; however, this reaction is unique and is discussed in more detail below. 3-Bromopropionate (Br3A) was not tested although it has been reported not to form the MCRXA signal (18). Br3A is an analog of 2-bromoethanesulfonate (BES) and like BES ([I]0.5 V = 2 μM), quenches the MCRred1 signal by the oxidation of the enzyme from Ni(I) to an EPR-silent Ni (34) state, thus BES and hence, Br3A appears to act as irreversible inhibitors of MCR (18).

The MCRXA species formed from the longer (X = 11, 12, 15, and 16) brominated acids accumulate to less than 10% within 1 min at 25 °C, indicating that these complexes form transient species that form and decay more rapidly than the time it takes to hand mix and freeze the samples. When these brominated acids were reacted with MCRred1 at 4 °C and frozen within ~30 secs in an EPR tube, accumulation of the corresponding MCRXA species markedly increased (Table 1). We suggest that the MCRXA complexes formed with the longer brominated acids are not well anchored to the active site and, thus, escape from the radical cage and dissociate rapidly from the substrate binding channel in MCR. To better understand the reactions of MCRred1 with the bromoacids, stopped flow experiments were performed.

Reaction of MCRred1 with brominated acids and MCRXA formation followed by stopped-flow

Formation of the EPR-active MCRXA state is accompanied by a 35 nm red shift relative to MCRred1 (Figure 3). Exhibiting absorption maxima at 420 nm, the UV-visible absorption spectra of MCRXA resemble those of MCRPS (alkyl-Ni(III)), MCRox1 (RS-Ni(III)), and MCRsilent (Ni(II)).

Figure 3.

Figure 3

UV-visible spectral changes associated with reaction of MCRred1 with Br7A and BPS. MCRred1 (8.2 μM (solid line)) was incubated with 400 μM Br7A (dashed line) or 219 μM BPS (dotted line) in 50 mM Tris-HCl (pH 7.6) with 0.1 mM Ti(III) citrate at 20 °C.

Stopped-flow UV-visible spectroscopy was used to obtain kinetic parameters for the reaction of MCRred1 with the brominated acids by monitoring the absorption bands at 385 nm and 420 nm to follow the decay of MCRred1 and formation of MCRXA, respectively. For the reaction with each of the brominated acids, the rate constant (k) could be obtained by a single exponential equation, which adequately fit the data. The rate of decay of MCRred1 matches the rate of MCRXA formation, which indicates that there are no intermediates in the conversion of MCRred1 to MCRXA, or that any intermediates are too transient to be observed. These rate constants were plotted versus the BrXA concentrations to determine the second order rate constant (kmax/KM) for MCRXA formation as exemplified for Br7A in Figure 4. The second order rate constants for formation of the MCRXA complexes with the shorter and medium length acids (X = 5-10) are between 20-60 M-1 s-1 (Table 1, Figures S1-S5), with the exception of MCR7A, which has a second order rate constant of 140 M-1 s-1. The second order rate constants for formation of MCR11A, MCR12A and MCR15A (Table 1, Figures S6-S8) are significantly higher. The kmax and KM values for MCR16A could not be determined due to solubility issues involved with Br16A concentrations above 0.5 mM. However, with the available concentrations, a linear fit of the data established a second order rate constant of 60 M-1 s-1 (Table 1, Figure S9).

Figure 4.

Figure 4

Dependence of kobs for MCR7A on Br7A concentration. 10 μM MCRred1 was converted to MCR7A by the addition of different concentrations of Br7A in 0.5 M Tris-HCl, pH 7.6 containing 0.2 mM Ti(III) citrate. The data were fit to a 2-parameter hyperbolic equation with a kmax of 2.8 ± 0.4 s-1 and KM of 21 ± 8 mM and a second order rate constant of 140 ± 57 M-1 s-1.

The kinetics for formation of these MCRXA complexes can be compared to those for formation of their similarly sized sulfonate cousins, MCRPS and MCRBS, and to the rate of methane formation from methyl-SCoM. MCR4A is formed with an overall second order rate constant of 170 M-1 s-1, which is 1000 times lower than that for formation of MCRPS (2.3 × 103 M-1 s-1 at 25 °C) (17, 18, 22). However, the kmax values for these reactions are nearly identical (MCRPS, 17s-1, MCR4A, 15 s-1); therefore, the decreased catalytic efficiency for the formation of MCR4A relative to MCRPS comes exclusively from the difference in KM values for these two substrates, ~90 mM for Br4A and ~0.09 mM for BPS. On the other hand, the kmax/KM for MCR4A formation is only 5.4-fold lower than the kcat/KM for methane formation from methyl-SCoM (930 M-1 s-1 at 20 °C, 1.9 × 104 M-1 s-1 at 65 °C) and the kmax value is actually 3-fold higher than the kcat for methane formation at 20 °C. The second order rate constant for MCR5A formation (31 M-1s-1) is 70-fold lower than that for formation of MCRBS (2.3 × 103 M-1s-1), the analogous sulfonate complex, resulting from a 7-fold increase in KM and a ~10-fold decrease in kmax. The reactions of MCRred1 with Br7A and Br8A exhibit kinetic parameters similar to those of the shorter bromoacids with near or complete conversion to MCR7A and MCR8A. For example, MCR7A formation occurs with a second order rate constant of 140 M-1 s-1, the kmax values are rather high (~2-3 s-1) and the KM values are similar to those of methyl-SCoM. We conclude that the short chain brominated acids are positioned in the active site much like methyl-SCoM and HSCoM and react similarly to BPS.

There is a marked drop in both kmax and KM values for the reactions of MCRred1 with Br9A, Br10A, Br12A, Br15A and Br16A (Table 1, Figures S4, S5 and S7-S9). The KM values for most of these BrXA fall in the range of the KM for CoBSH (~0.2 mM) (21) and the values of kmax/KM for the reactions with Br11A, Br12A and Br15A are similar to the kcat/KM for CoBSH (2.2 × 103 M-1s-1, 20 °C) in methane formation (26), suggesting that these long chain bromoacids are recognized by MCR as CoBSH analogs. Based on a simple structural analysis using ChemDraw (Figure 5), the negatively charged oxygen on the carboxyl group of Br10A would be in the same position as the carboxylate oxygen of CoBSH and the oxygen from the carboxylate of Br12A would occupy the same position as the phosphate oxygen of CoBSH. The corresponding MCRXA complexes decay more rapidly than those formed from the shorter BPS-like bromoacids, with <10 % of the MCRXA complex accumulating when mixed at room temperature (Table 1). The yield of EPR-active MCRXA could be increased to ~20-40 % by performing the reaction at 4 °C.

Figure 5.

Figure 5

Comparison of the structures of Br11A and CoBSH. Two alternative conformations (a and b) are shown by the solid and dotted lines.

Although Br11A reacts very rapidly with MCRred1, we did not observe saturation even at 60 mM concentrations; therefore, there is a relatively high standard error associated with both the KM (200 mM) and kmax (380 s-1) values shown in Table 1. The second order rate constant for MCR11A formation determined from a linear fit (1500 ± 80 M-1 s-1) is more accurate and is in reasonable agreement with that determined from a hyperbolic fit (1900 M-1 s-1). Due to the low solubility of Br15A and Br16A, kinetic parameters were determined using brominated acid concentrations no greater than 0.5 mM. Regardless, the kobs/KM values are comparable to that obtained with Br11A; for example, for the reaction of Br15A with MCRred1, the second order rate constant is 1600 M-1s-1 (Figure S8). Then, with Br16A, saturation could not be reached and the kmax/KM value, determined from a linear fit is 57 M-1s-1.

Reaction of MCRred1 with Br4A - self-reactivation of MCR4A to form MCRred

When the reaction between MCRred1 and Br4A was monitored by UV-visible and EPR spectroscopy, MCRred1 was shown to quantitatively convert to MCR4A., as shown earlier (17, 18, 22); however, when lower concentrations (~0.2 mM) of Br4A were used, a rapid decrease in absorbance at 385 nm due to formation of MCR4A was observed, followed by a gradual increase in absorbance at 385 nm after ~1 min (Figure 6), which corresponds to the reformation of MCRred1. The regeneration of MCRred1 occurred at either pH 10.0 or pH 7.6 in the absence of free thiols, which were shown to convert MCRPS to MCRred1 at pH 10.0 (17, 18, 22).

Figure 6.

Figure 6

Formation of MCR4A followed by regeneration of MCRred1. The formation or decay of MCR4A and MCRred1 were monitored at 385 nm (solid line) and 420 nm (open triangles) by UV-visible spectroscopy. MCRred1 (10 μM) was reacted with 0.2 mM Br4A in 200 mM ammonium carbonate, pH ~ 10. The data were fit to three-component sequential equations with the following parameters: for the absorbance changes at 385: k1, 0.037 ± 0.003 s-1; k2 = 0.0067 ± 0.0003 s-1; for the absorption changes at 420 nm: k1, 0.036 ± 0.001 0 s-1, k2 0.0054 ± 0.0007 s-1.

The rate of MCR4A generation depends on the Br4A concentration, with a second order rate constant of 170 ± 12 M-1 s-1 (kmax, 15 s-1; KM, 89 mM) (Figure S10), while the rate constant for regeneration of MCRred1 (0.0067 s-1) is 2200-fold slower and is independent of the Br4A concentration. At low concentrations of Br4A (i.e., 0.2 mM), there is complete (100%) conversion of MCR4A to MCRred1 (Figure 6). However, at higher concentrations of Br4A, MCR4A is only partially converted to MCRred1 and, at Br4A concentrations greater than 8 mM, there is no appreciable regeneration and the absorbance at 420 nm increases to a limiting value in a single exponential fashion. The apparent conundrum is that conversion of alkyl-Ni(III) to Ni(I) and an alkane requires a two-electron input into the Ni(III) center and no redox mediators are present; thus, it was important to determine the product of this MCRred1 regeneration reaction.

Mass spectrometric (MS) evidence for ester formation from the self-reactivation reaction of MCR4A

Mass spectrometry was used to identify the product of the self-reactivation reaction of MCRred1 with Br4A (Figure 7). In the negative ion mode (NIM), the major peak has an m/z value of 250.8. This corresponds to the molecular formula C8H13O4Br with an exact mass of 252, which can be assigned to the bromo carboxy ester, 4-(4-bromobutanoyloxy)butanoic acid, Br-(CH2)3-COO-(CH2)3-COOH. In NIM, the loss of a proton from the carboxylic terminal group of the bromo-carboxy ester product, Br-(CH2)3-COO-(CH2)3-COOH, will give the expected m/z value of 251, i.e., (252 - 1)/1, consistent with the experimentally observed value (Inset, Figure 7). Confirmation that the product is the ester was obtained by MS-MS analysis of the parent ion peak (m/z 250.8).

Figure 7.

Figure 7

NIM MS-MS identification of the fragmented/daughter ions from the bromocarboxy ester product formed from the “self-reactivation” of MCR4A to MCRred1. MCRred1 (10 μM) was reacted with 2.0 mM Br4A in 20 mM ammonium carbonate, pH ~ 10. Inset: NIM ES-MS identification of the bromo-carboxy ester product formed from the “self-reactivation” of MCR4A to MCRred1.

Daughter ion peaks were primarily observed at m/z 149.5, 164.8, 171.7 (Figure 7). The peak at m/z 171.7 arises from loss of bromine from the parent ion to give C8H13O4, with an exact mass of 173.2, followed by deprotonation of the carboxylic acid to give the negative ion, [C8H13O4]-, with a calculated m/z of 172, i.e, (252 - 79 = [173 - 1/1]=172), the fragment labeled ‘c’ in Figure 7. Thus, the ester can cleave at different positions marked ‘a’, ‘b’, and “c” (Figure 7) to form daughter ions having molecular formulae C4H6O2Br, C4H6OBr and C8H13O4, and the peaks marked ‘a’ and ‘b’ agree the experimentally observed m/z values of 164.8 and 149.5, respectively.

When the negative control experiment was performed in absence of enzyme, the product was not observed in either NIM or positive ion mode (PIM); however, a peak corresponding to the bromide was observed in NIM and the remaining fragment after de-bromination, which presumably is a positive species, was observed in PIM. Thus, the reaction of MCRred1 with Br4A generates the alkyl-Ni(III) species MCR4A. Another molecule of Br4A reacts with MCR4A to generate the ester, 4-(4-bromobutanoyloxy)butanoic acid. Two possible mechanisms by which this condensation could occur are considered in the Discussion.

MCRXA is reactivated to MCRred1 by thiols

It has been recently observed that the MCRPS complex can be reconverted to active MCRred1 by nucleophilic attack of various thiolates on the carbon bound to nickel. To determine if MCRXA reacts similarly with thiols, we incubated the MCRXA complexes with HSCoM and followed the decrease in absorbance of MCRXA at 420 nm and the increase in MCRred1 at 385 nm (Figure 8). Since MCRXA and MCRsilent have similar UV-visible spectra, we also followed the reaction by EPR spectroscopy (inset, Figure 8).

Figure 8.

Figure 8

UV-visible spectral changes associated with the regeneration of MCRred1 from MCR7A incubated with 20 mM HSCoM. MCRred1 (11.52 μM (solid line)) was treated with 100 μM Br7A (dotted line) and the MCR7A formed was incubated with 20 mM HSCoM in 1M TAPS-Na (pH ~ 10) at 20 °C and the absorbance was recorded every 6 mins for over 40 mins. Inset: Representative EPR spectra of MCRred1 (solid line) MCR7A (dotted line) and regeneration of MCR7A to MCRred1 (dashed line).

The rate constant for conversion of the different MCRXA species to MCRred1 is in the range 0.003-0.012 s-1 (Table 2), which is similar to the rate constant for regeneration by HSCoM of MCRBS (kmax of 0.006 s-1) and MCRPS (kmax is 0.011 s-1). We did not observe a HSCoM concentration dependence for the rate of conversion of MCRXA to MCRred1; however, the reactions with MCRBS (KM = 17 mM, Figure S11) and MCRPS (KM = 2.8 mM (21)) exhibit clear hyperbolic binding curves.

Table 2.

Regeneration of MCRred1 from MCRXA using 20 mM HSCoM. Experiments were performed in 0.5 M TAPS (pH 10) at 25 oC.

Chemical Name Reactivation of MCRXA MCRXA → MCRred1 (% reactivation)a kobs (s-1)
Br5A Yes 46 0.012 + 0.001
Br6A Yes 65 0.006 ± 0.001
Br7A Yes 81 0.006 ± 0.001
Br8A Yes 31 0.003 ± 0.001
Br9A No Negligible NA
a

The % reactivation represents the percentage conversion of MCRXA to MCRred1. For details of experimental conditions, refer to experimental section.

Among the different brominated acids shown in Table 2, the percent conversion of MCRXA to MCRred1 vary, with a maximum of about 80 % conversion of MCR7A to MCRred1 (inset, Figure 8). Any EPR-inactive Ni species that is formed most likely decayed into Ni(II)-MCRsilent. Furthermore, we did not observe conversion of MCRXA, formed from the longer brominated acids (9, 10, 11, 12, 15 and 16-BrA), to MCRred1 when these MCRXA species are incubated with HSCoM. Perhaps the MCRXA complex formed from the longer acids did not reactivate because the active site may be plugged, preventing access of thiols to the active site.

Mass spectrometry evidence that a thioether product is formed from the reaction of MCRXA and HSCoM

We used MS in NIM to identify the product of the reaction between MCR5A and HSCoM, as CoM-S-5A, with an m/z value 241.3, which corresponds to the molecular formula C7H14O5S2 with an exact mass of 241.3 after loss of a proton (inset, Figure 9). This assignment was confirmed by MS-MS analysis of the parent ion peak at m/z 241.3, which yields the fragmentation pattern shown in Figure 9.

Figure 9.

Figure 9

NIM-MS/MS spectrum of the product of the reaction of MCR5A with HSCoM. 20 μM MCRred1 was reacted with 1mM Br5A to form MCR5A, which was reacted with 1 mM HSCoM in 500 mM ammonium carbonate pH ~ 10.0. Inset: Original NIM-MS spectrum of the reaction product.

Daughter ion peaks were observed at m/z 140.9, 132.9, 107.0, 99.0 and 81.0. The daughter ion at m/z 132.9, labeled “b” is assigned to the 5-thiopentanoic acid fragment, with a molecular formula C5H9O2S in which the C-S bond is cleaved. The remaining fragment ion is desulfo-CoM with a molecular formula C2H4SO3 and m/z of 107.0 (fragment labeled ‘c’). The daughter ion peak at m/z 140.9 (peak labeled ‘a’) corresponds to C2H6O3S2 with an exact mass of 141.97, which is formed when the thioether (S-C) bond is cleaved on the pentanoic acid side of the thioether group. A secondary ion that is generated from this S-C fragmentation is pentanoate, with an m/z of 99.0 (fragment and peak labeled ‘d’). The peak at m/z 81.0, labeled ‘e’, is assigned to the sulfonate group that is cleaved from various ions.

A negative control experiment performed in the absence of enzyme gave a peak at m/z 242.3, which is only one mass unit higher than the expected product (CoM-S-5A, m/z 241.3). In order to confirm if the 242.3 peak corresponds to the product, MS-MS was performed; the resulting fragmentation pattern was not consistent with that observed for CoM-S-5A product, which rules out the possibility of the thioether product in the absence of enzyme.

MS coupled with MS-MS also verified formation of the thioether products from the reactions of MCR6A and MCR7A with HSCoM. Thus, the MS data reveal that the reaction of HSCoM with MCRXA generates a thioether product, like the reaction with MCRBS and MCRPS.

Discussion

We studied the reaction of MCRred1 with a series of brominated carboxylic acids by EPR and UV-visible spectroscopy and by kinetics. These reactions, as with BPS, apparently involve nucleophilic attack of Ni(I)-MCRred1 on the terminal carbon adjacent to the bromine atom to eliminate bromide and generate the EPR-active MCRXA species. Compounds that give rise to the MCRXA EPR signal can be abbreviated as BrXA and are generalized by the following structure: Br-(CH2)3-15-COO-; where X is the alkyl linker and is ~3-15 carbons long, and A is the terminal anionic carboxylate group. Based on the near identity of the MCRXA EPR signal to that of the MCRPS (21), we can confidently assign MCRXA as a Ni(III)-alkyl carboxylate. As with MCRPS, the lack of detectable hyperfine splitting from the bromide (I = 3/2) demonstrates that it is not near the paramagnetic center, suggesting that the bromide undergoes elimination in formation of the MCRXA state.

The BrXA's were characterized by their reactivity with MCRred1 to form MCRXA (Table 1), their ability to accumulate MCRXA (Table 1), and by the rate at which the respective MCRXA complexes react with thiolates (-SCoM) to form MCRred1 and the CoMS-XA thioether (Table 2). Accumulation of MCRXA (in the absence of the thiolate) is a function of the rate of MCRXA formation and its decay to form XA and the EPR-silent Ni(II) MCRsilent state. All of these bromoacids form EPR-active MCRXA species and fall into two classes, based on their reactivity (Figure S12).

The shorter brominated acids, Br4A to Br8A, react rapidly with MCRred1 to form the MCRXA state, exhibit high values of KM and kmax for MCRXA formation, and accumulate nearly quantitatively in this state; furthermore, these compounds react with HSCoM to form a thioether and regenerate MCRred1. These properties indicate that the short bromoacids mimic binding of methyl-SCoM (KM = 5.0 mM, (31)), with their carboxylate groups interacting with Arg120.

The MCR4A complex formed from the short bromoalkanoic acid, Br4A, undergoes conversion to MCRred1 in the absence of thiolate. One would expect Br4A to be reactive, since like BPS (the most potent inhibitor of MCR), its bromide is adjacent to an electrophilic carbon atom that is four bonds (~ 4.8 Å) from the negatively charged oxygen of the carboxylate. Accordingly, the kmax values for formation of MCRPS and MCR4A are nearly identical (~15 s-1). Therefore, we propose that MCRred1 reacts with Br4A to form MCR4A, an alkyl-Ni(III) species as with the other brominated substrate analogs. However, unlike BPS, with three oxygen atoms on the sulfonate that firmly anchor it to the active site, the carboxylate of Br4A is short of one oxygen, and thus would be held by weaker interactions (as indicated by its high KM value). Regardless, it is likely that the alkanoate group is positioned in the active site with the methylene group bound to Ni and the carboxylate group bound to Arg120. Then, two pathways could be considered for formation of 4-(4-bromobutanoyloxy)butanoic acid, the product that is observed by mass spectrometry. In Pathway I, a second molecule of Br4A could enter the active site and nucleophilically attack the nickel-bound electrophilic carbon-4 to form the bromocarboxy ester and MCRred1. The nucleophilic attack of the second Br4A is similar to the reaction of HSCoM on the MCRXA species (where X = 5-8). In fact, the rate constants for formation of the thioethers and the bromocarboxy ester are similar. Another possibility, shown in pathway II, Figure S13 is that the electrophilic methylene group bound to Ni in MCR4A could undergo intramolecular attack by the negatively charged oxygen of the carboxylate to form a five-membered butyrolactone and MCRred1. Then, another molecule of Br4A would react with the butyrolactone in solution or in the enzyme active site to generate the bromocarboxy ester.

The longer bromoacids, Br9A to Br16A, apparently mimic CoBSH (KM = 0.2 mM, 21) since they bind more tightly to MCR, exhibit second-order rate constants for formation of MCRXA that are similar to those for CoBSH in methane synthesis, and accumulate to a much lower extent than the shorter brominated acids. These compounds likely bind with their carboxyl group interacting with the solvent and the positively charged residues at the upper lip of the channel with the bromoalkyl chain reaching toward the nickel center, where it could react rapidly and form the MCRXA complex. The unstable alkyl-Ni(III) complex then rapidly decays to an EPR silent Ni(II) state. Perhaps this is due to homolytic cleavage of the nickel carbon bond giving Ni(II)-MCRsilent and the corresponding alkanoic acid radical, which could abstract a hydrogen atom from the environment of protein to form the alkanoic acid (21).

Conclusion

The present studies reveal that MCRred1 can react with a wide range of brominated acids giving rise to an alkyl-Ni(III) complex, called MCRXA, which exhibits UV-visible and EPR spectra that are nearly identical to the Ni(III)-alkylsulfonate species formed from MCRPS. Thus, the MCRXA complex resembles the methyl-nickel(III) species in the first step of one of the mechanisms (Mechanism I) proposed for methane formation from the natural substrates. The present studies reveal the flexibility of the active site of MCR to accommodate a broad array of substrates. The stable MCRXA species (where X = 5-8) can undergo attack by nucleophilic thiols to form a thioether product and regenerate the active Ni(I) MCRred1 state, while MCR4A converts to MCRred1 in the absence of a thiol. The unexpected reactivity and flexibility of the MCR active site to accommodate a broad range of substrates provides a molecular ruler for the substrate channel in MCR.

Supplementary Material

1File004

ACKNOWLEDGMENT

We thank Dr. Ashraf Raza for assistance in running mass spectrometric experiments.

This work was partly supported by a grant from the Department of Energy (SWR, DE-FG03-ER20297) and by an NSF grant (DBI-0552648) that supported Derek Lyons’ research as part of a summer REU. The mass spectrometry instrumentation was purchased with funds from an NIH grant (1P20RR17675) to help support the Instrumentation Core of the Redox Biology Center at UNL.

Abbreviations

MCR

Methyl-coenzyme M reductase

methyl-SCoM

methyl-coenzyme M or, 2-(methylthio)ethanesulfonate

HSCoM

coenzyme M or, 2-thioethanesulfonate

CoBSH

coenzyme B or N-7-mercaptoheptanoylthreonine phosphate

BPS

3-bromopropane sulfonate

BBS

4-bromobutane sulfonate

MCRred1

MCR exhibiting the Ni (I) EPR signal

MCRPS

MCR exhibiting alkyl-Ni(III) signal arising from reaction of MCRred1 with BPS

MCRBS

MCR exhibiting the alkyl-Ni(III) signal from the reaction of MCRred1 with BBS

MCRXA

MCR exhibiting the alkyl-Ni(III) signal from reaction of MCRred1 with bromocarboxylic acids

NIM

negative ion mode

Footnotes

Supporting Information Available. Eight figures showing second order rate constant determination for the formation of various MCRXA complexes. This material is available free of charge via the Internet at http://pubs.acs.org

References

  • 1.Thauer RK. Biochemistry of methanogenesis: a tribute to Marjory Stephenson. 1998 Marjory Stephenson Prize Lecture. Microbiology. 1998;144(Pt 9):2377–406. doi: 10.1099/00221287-144-9-2377. [DOI] [PubMed] [Google Scholar]
  • 2.DiMarco AA, Bobik TA, Wolfe RS. Unusual coenzymes of methanogenesis. Annu Rev Biochem. 1990;59:355–94. doi: 10.1146/annurev.bi.59.070190.002035. [DOI] [PubMed] [Google Scholar]
  • 3.Ellermann J, Kobelt A, Pfaltz A, Thauer RK. On the role of N-7-mercaptoheptanoyl-O-phospho-L-threonine (component B) in the enzymatic reduction of methyl-coenzyme M to methane. FEBS Lett. 1987;220:358–62. doi: 10.1016/0014-5793(87)80846-3. [DOI] [PubMed] [Google Scholar]
  • 4.Kruger M, Meyerdierks A, Glockner FO, Amann R, Widdel F, Kube M, Reinhardt R, Kahnt J, Bocher R, Thauer RK, Shima S. A conspicuous nickel protein in microbial mats that oxidize methane anaerobically. Nature. 2003;426:878–81. doi: 10.1038/nature02207. [DOI] [PubMed] [Google Scholar]
  • 5.Diekert G, Jaenchen R, Thauer RK. Biosynthetic evidence for a nickel tetrapyrrole structure of factor F430 from Methanobacterium thermoautotrophicum. FEBS Lett. 1980;119:118–20. doi: 10.1016/0014-5793(80)81011-8. [DOI] [PubMed] [Google Scholar]
  • 6.Diekert G, Klee B, Thauer RK. Nickel, a component of factor F430 from Methanobacterium thermoautotrophicum. Arch Microbiol. 1980;124:103–6. doi: 10.1007/BF00407036. [DOI] [PubMed] [Google Scholar]
  • 7.Whitman WB, Wolfe RS. Presence of nickel in factor F430 from Methanobacterium bryantii. Biochem Biophys Res Commun. 1980;92:1196–201. doi: 10.1016/0006-291x(80)90413-1. [DOI] [PubMed] [Google Scholar]
  • 8.Ermler U, Grabarse W, Shima S, Goubeaud M, Thauer RK. Crystal structure of methyl-coenzyme M reductase: the key enzyme of biological methane formation. Science. 1997;278:1457–62. doi: 10.1126/science.278.5342.1457. [DOI] [PubMed] [Google Scholar]
  • 9.Goubeaud M, Schreiner G, Thauer RK. Purified methyl-coenzyme-M reductase is activated when the enzyme-bound coenzyme F430 is reduced to the nickel(I) oxidation state by titanium(III) citrate. Eur J Biochem. 1997;243:110–4. doi: 10.1111/j.1432-1033.1997.00110.x. [DOI] [PubMed] [Google Scholar]
  • 10.Rospert S, Bocher R, Albracht SP, Thauer RK. Methyl-coenzyme M reductase preparations with high specific activity from H2-preincubated cells of Methanobacterium thermoautotrophicum. FEBS Lett. 1991;291:371–5. doi: 10.1016/0014-5793(91)81323-z. [DOI] [PubMed] [Google Scholar]
  • 11.Craft JL, Horng YC, Ragsdale SW, Brunold TC. Nickel oxidation states of F(430) cofactor in methyl-coenzyme M reductase. J Am Chem Soc. 2004;126:4068–9. doi: 10.1021/ja038082p. [DOI] [PubMed] [Google Scholar]
  • 12.Harmer J, Finazzo C, Piskorski R, Bauer C, Jaun B, Duin EC, Goenrich M, Thauer RK, Van Doorslaer S, Schweiger A. Spin density and coenzyme M coordination geometry of the ox1 form of methyl-coenzyme M reductase: a pulse EPR study. J Am Chem Soc. 2005;127:17744–55. doi: 10.1021/ja053794w. [DOI] [PubMed] [Google Scholar]
  • 13.Becker DF, Ragsdale SW. Activation of methyl-SCoM reductase to high specific activity after treatment of whole cells with sodium sulfide. Biochemistry. 1998;37:2639–47. doi: 10.1021/bi972145x. [DOI] [PubMed] [Google Scholar]
  • 14.Albracht SPJ, Ankel-Fuchs D, Böcher R, Ellermann J, Moll J, van der Zwann JW, Thauer RK. Five new EPR signals assigned to nickel in methyl-coenzyme M reductase from Methanobacterium thermoautotrophicum, strain Marburg. Biochimica et Biophysica Acta. 1988;955:86–102. [Google Scholar]
  • 15.Mahlert F, Bauer C, Jaun B, Thauer RK, Duin EC. The nickel enzyme methyl-coenzyme M reductase from methanogenic archaea: In vitro induction of the nickel-based MCR-ox EPR signals from MCR-red2. J Biol Inorg Chem. 2002;7:500–13. doi: 10.1007/s00775-001-0325-z. [DOI] [PubMed] [Google Scholar]
  • 16.Rospert S, Voges M, Berkessel A, Albracht SP, Thauer RK. Substrate-analogue-induced changes in the nickel-EPR spectrum of active methylcoenzyme-M reductase from Methanobacterium thermoautotrophicum. Eur J Biochem. 1992;210:101–7. doi: 10.1111/j.1432-1033.1992.tb17396.x. [DOI] [PubMed] [Google Scholar]
  • 17.Hinderberger D, Piskorski RP, Goenrich M, Thauer RK, Schweiger A, Harmer J, Jaun B. A nickel-alkyl bond in an inactivated state of the enzyme catalyzing methane formation. Angew Chem Int Ed Engl. 2006;45:3602–7. doi: 10.1002/anie.200600366. [DOI] [PubMed] [Google Scholar]
  • 18.Goenrich M, Mahlert F, Duin EC, Bauer C, Jaun B, Thauer RK. Probing the reactivity of Ni in the active site of methyl-coenzyme M reductase with substrate analogues. J Biol Inorg Chem. 2004;9:691–705. doi: 10.1007/s00775-004-0552-1. [DOI] [PubMed] [Google Scholar]
  • 19.Ellermann J, Rospert S, Thauer RK, Bokranz M, Klein A, Voges M, Berkessel A. Methyl-coenzyme-M reductase from Methanobacterium thermoautotrophicum (strain Marburg). Purity, activity and novel inhibitors. Eur J Biochem. 1989;184:63–8. doi: 10.1111/j.1432-1033.1989.tb14990.x. [DOI] [PubMed] [Google Scholar]
  • 20.Brenner MC, Zhang H, Scott RA. Nature of the low activity of S-methyl-coenzyme M reductase as determined by active site titrations. J Biol Chem. 1993;268:18491–5. [PubMed] [Google Scholar]
  • 21.Goenrich M, Duin EC, Mahlert F, Thauer RK. Temperature dependence of methyl-coenzyme M reductase activity and of the formation of the methylcoenzyme M reductase red2 state induced by coenzyme B. J Biol Inorg Chem. 2005;10:333–42. doi: 10.1007/s00775-005-0636-6. [DOI] [PubMed] [Google Scholar]
  • 22.Kunz RC, Horng YC, Ragsdale SW. Spectroscopic and kinetic studies of the reaction of bromopropanesulfonate with methyl-coenzyme M reductase. J Biol Chem. 2006;281:34663–76. doi: 10.1074/jbc.M606715200. [DOI] [PubMed] [Google Scholar]
  • 23.Lahiri GK, Stolzenberg AM. Facile formation of hexahydroporphyrin complexes by reduction of octaethylisobacteriochlorinnickel(II) Angew.Chem.Int.Ed.Engl. 1993;32:429–432. [Google Scholar]
  • 24.Lin S-K, Jaun B. Coenzyme F430 from methanogenic bacteria: detection of a paramagnetic methylnickel(II) derivative of the pentamethyl ester by 2H-NMR spectroscopy. Helv. Chem. Acta. 1991;74:1725–1738. [Google Scholar]
  • 25.Lin S-K, Jaun B. Coenzyme F430 from methanogenic bacteria: mechanistic studies on the reductive cleavage of sulfonium ions catalyzed by F430 pentamethyl ester. Helv. Chem. Acta. 1992;75:1478–1490. [Google Scholar]
  • 26.Horng YC, Becker DF, Ragsdale SW. Mechanistic studies of methane biogenesis by methyl-coenzyme M reductase: evidence that coenzyme B participates in cleaving the C-S bond of methyl-coenzyme M. Biochemistry. 2001;40:12875–85. doi: 10.1021/bi011196y. [DOI] [PubMed] [Google Scholar]
  • 27.Banerjee R, Ragsdale SW. The many faces of Vitamin-B12: Catalysis by Cobalamin dependent enzymes. Annu Rev Biochem. 2003;72:209–247. doi: 10.1146/annurev.biochem.72.121801.161828. [DOI] [PubMed] [Google Scholar]
  • 28.Pelmenschikov V, Blomberg MR, Siegbahn PE, Crabtree RH. A mechanism from quantum chemical studies for methane formation in methanogenesis. J Am Chem Soc. 2002;124:4039–49. doi: 10.1021/ja011664r. [DOI] [PubMed] [Google Scholar]
  • 29.Pelmenschikov V, Siegbahn PE. Catalysis by methyl-coenzyme M reductase: a theoretical study for heterodisulfide product formation. J Biol Inorg Chem. 2003;8:653–62. doi: 10.1007/s00775-003-0461-8. [DOI] [PubMed] [Google Scholar]
  • 30.Wackett LP, Honeck JF, Begley TP, Wallace V, Orme-Johnson WH, Walsh CT. Substrate analogues as mechanistic probes of methyl-S-coenzyme M reductase. Biochemistry. 1987;26:6012–6018. doi: 10.1021/bi00393a010. [DOI] [PubMed] [Google Scholar]
  • 31.Zehnder AJ, Wuhrmann K. Titanium (III) citrate as a nontoxic oxidation-reduction buffering system for the culture of obligate anaerobes. Science. 1976;194:1165–6. doi: 10.1126/science.793008. [DOI] [PubMed] [Google Scholar]
  • 32.Schonheit P, Moll J, Thauer RK. Nickel, cobalt, and molybdenum requirement for growth of Methanobacterium thermoautotrophicum. Arch Microbiol. 1979;123:105–7. doi: 10.1007/BF00403508. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1File004

RESOURCES